文献速递特殊人群用药

孕期与哺乳期药理学研究的创新方法:HIV领域的观点与经验

Innovative Approaches for Pharmacology Studies in Pregnant and Lactating Women: A Viewpoint and Lessons from HIV.
PubMed 文献 · Clin Pharmacokinet · 2020-01-01

孕期用药常缺乏药代动力学与安全性数据,抗逆转录病毒药物尤为突出,因孕妇通常不纳入药物获批前的临床试验。目前数据多来自上市后机会性妊娠研究,导致监管批准与孕期特异性药代动力学和安全性数据间存在显著时间差。本文讨论新方法以在药物开发早期获取这些关键数据,并强调需整合体外、离体、计算机模拟和体内等多重方法。

要点

  • 孕妇通常被排除在药物获批前的临床试验之外,孕期药代动力学与安全性数据常滞后于监管批准。
  • 现有数据多来自上市后机会性妊娠研究,导致关键孕期用药信息获取延迟。
  • 需整合体外、离体、计算机模拟和体内等多重方法,加速孕期与哺乳期药理学数据获取。

核心结论

  • 需要采用整合多种新方法学的策略,以加速孕期和哺乳期药理学数据的获取。

研究设计与样本

  • 本文为观点类文章,讨论孕期与哺乳期药理学研究的创新方法,并以HIV领域经验为例。

主要发现

  • 孕妇通常不纳入药物获批前的临床试验,孕期药代动力学和安全性数据多在上市后通过机会性妊娠研究生成。
  • 从药物初始监管批准到获得孕期特异性药代动力学和安全性数据之间存在显著时间差。
  • 在缺乏数据期间,医疗提供者缺少关于人胎盘转运、胎儿暴露、孕期最佳母亲剂量及母婴药物毒性(包括致畸风险)的关键信息。

临床怎么用

  • 临床应认识到孕期用药常缺乏药代动力学和安全性数据,尤其在抗逆转录病毒药物领域。
  • 在孕期用药决策时,需关注人胎盘转运、胎儿暴露、孕期母亲剂量及母婴毒性等关键信息缺口。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Medication use during pregnancy in the absence of pharmacokinetic and safety data is common, particularly for antiretrovirals, as pregnant women are not usually included in clinical trials leading to drug licensure. To date, data are typically generated through opportunistic pregnancy studies performed in the postmarketing setting, leading to a substantial time-lag between initial regulatory approval of a drug and availability of essential pregnancy-specific pharmacokinetic and safety data. During this period, health care providers lack key information on human placental transfer, fetal exposure, optimal maternal dosing in pregnancy, and maternal and fetal drug toxicity, including teratogenicity risk. We discuss new approaches that could facilitate the acquisition of these critical data earlier in the drug development process, aiding clinicians and patients in making informed decisions on drug selection and dosing during pregnancy. An integrated approach utilizing multiple novel methodologies (in vitro, ex vivo, in silico and in vivo) is needed to accelerate the availability of pharmacology data in pregnancy and lactation.

来源:Clin Pharmacokinet,查看原文。版权归原作者所有。

引用

  1. Eke AC, Olagunju A, Best BM, et al. Innovative Approaches for Pharmacology Studies in Pregnant and Lactating Women: A Viewpoint and Lessons from HIV. Clin Pharmacokinet. 2020. PMID: 32757103. doi:10.1007/s40262-020-00915-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。